Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Metz

Showing results (191-200 of 258) with videos related to

Pageof 26
Sort By:
The British Journal of Dermatology|June 16, 2026
Further Validation and Threshold Determination of Brazilian-Portuguese Version of the CU-Q2oL QuestionnaireJoão Marcelino, Felix Aulenbacher, Helena Pereira, et al.
The Journal of Allergy and Clinical Immunology|November 14, 2016
Serum autoreactivity predicts time to response to omalizumab therapy in chronic spontaneous urticariaJanine Gericke, Martin Metz, Tatevik Ohanyan, et al.
Allergo Journal : Interdisziplinare Zeitschrift Fur Allergologie Und Umweltmedizin : Organ Der Deutschen Gesellschaft Fur Allergie- Und Immunitatsforschung|March 31, 2021
Andrea Bauer, Heinrich Dickel, Thilo Jakob, et al.
Allergy|May 26, 2025
Anti-KIT Barzolvolimab for Chronic Spontaneous UrticariaMarcus Maurer, Martin Metz, John Anderson, et al.
Allergo Journal International|March 1, 2021
Expert consensus on practical aspects in the treatment of chronic urticariaAndrea Bauer, Heinrich Dickel, Thilo Jakob, et al.
Qatar Medical Journal|November 29, 2023
CRUSE - What the first 100 days have taught usSophia Neisinger, Bernardo Sousa Pinto, Aiste Ramanauskaite, et al.
The Journal of Allergy and Clinical Immunology|October 19, 2020
Mas-related G protein-coupled receptor X2 and its activators in dermatologic allergiesHelen Kühn, Pavel Kolkhir, Magda Babina, et al.
Allergy|July 6, 2018
Omalizumab normalizes the gene expression signature of lesional skin in patients with chronic spontaneous urticaria: A randomized, double-blind, placebo-controlled studyMartin Metz, Rebecca Torene, Sergio Kaiser, et al.
Journal of the American Academy of Dermatology|August 18, 2020
The characteristics and impact of pruritus in adult dermatology patients: A prospective, cross-sectional studyTomasz Hawro, Katarzyna Przybyłowicz, Max Spindler, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 5, 2024
The Mastocytosis Control Test: A Patient-Reported Outcome Measure Assessing Disease ControlFrank Siebenhaar, Senan Sofi, Sophia Neisinger, et al.
Pageof 26

Showing results (191-200 of 258) with videos related to

Sort By:
Pageof 26
The British Journal of Dermatology|June 16, 2026
Further Validation and Threshold Determination of Brazilian-Portuguese Version of the CU-Q2oL QuestionnaireJoão Marcelino, Felix Aulenbacher, Helena Pereira, et al.
The Journal of Allergy and Clinical Immunology|November 14, 2016
Serum autoreactivity predicts time to response to omalizumab therapy in chronic spontaneous urticariaJanine Gericke, Martin Metz, Tatevik Ohanyan, et al.
Allergo Journal : Interdisziplinare Zeitschrift Fur Allergologie Und Umweltmedizin : Organ Der Deutschen Gesellschaft Fur Allergie- Und Immunitatsforschung|March 31, 2021
Andrea Bauer, Heinrich Dickel, Thilo Jakob, et al.
Allergy|May 26, 2025
Anti-KIT Barzolvolimab for Chronic Spontaneous UrticariaMarcus Maurer, Martin Metz, John Anderson, et al.
Allergo Journal International|March 1, 2021
Expert consensus on practical aspects in the treatment of chronic urticariaAndrea Bauer, Heinrich Dickel, Thilo Jakob, et al.
Qatar Medical Journal|November 29, 2023
CRUSE - What the first 100 days have taught usSophia Neisinger, Bernardo Sousa Pinto, Aiste Ramanauskaite, et al.
The Journal of Allergy and Clinical Immunology|October 19, 2020
Mas-related G protein-coupled receptor X2 and its activators in dermatologic allergiesHelen Kühn, Pavel Kolkhir, Magda Babina, et al.
Allergy|July 6, 2018
Omalizumab normalizes the gene expression signature of lesional skin in patients with chronic spontaneous urticaria: A randomized, double-blind, placebo-controlled studyMartin Metz, Rebecca Torene, Sergio Kaiser, et al.
Journal of the American Academy of Dermatology|August 18, 2020
The characteristics and impact of pruritus in adult dermatology patients: A prospective, cross-sectional studyTomasz Hawro, Katarzyna Przybyłowicz, Max Spindler, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 5, 2024
The Mastocytosis Control Test: A Patient-Reported Outcome Measure Assessing Disease ControlFrank Siebenhaar, Senan Sofi, Sophia Neisinger, et al.
Pageof 26